GANX:Gain Therapeutics Inc Snapshot | Charting | News | Options
$1.95 NASDAQ 8:15a ET
March 18 '26 		Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
     GlobeNewswire
    Full Story →

    Headline News
    Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
    7:00a ET March 12 '26 GlobeNewswire
    Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
    7:00a ET February 19 '26 GlobeNewswire
    Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
    7:00a ET January 7 '26 GlobeNewswire
    More News →
    Day  25.57%Week  31.34%Month  7.73%More Charting →
    March 18 '26. Markets Closed.
    Last $1.95
    Day change   25.57%$0.67
    Open $2.5
    Gap at open $0.12
    Previous close $2.62
    Trading volume 3,086,364
    10 Day avg vol. 1,098,863
    Shares out. 38.5Mil
    Market cap. $75.0Mil
    Trading activity Above Avg.
    Previous data from yesterday, March 17 '26.

    Historical Price Performance
    3 month   13.33% 
    6 month   23.42% 
    1 year   18.07% 
    2 year   55.28% 

    Earnings
    Previous 12m -$0.64
    Next 12m Estimate -$0.65
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.